Critical Path Consortium To Allow Patents But Preserve Access For Partners
Executive Summary
The Predictive Safety Testing Consortium will allow companies to patent safety testing methodologies developed through the collaboration, but firms will be required to grant access to other members
You may also be interested in...
Pooled Antipsychotic Data Will Be Mined For Early Response Signals
A consortium of international drug companies hopes to leverage their pooled schizophrenia data into a means of determining which patient subgroups are most likely to respond to treatment during clinical trials.
Pooled Antipsychotic Data Will Be Mined For Early Response Signals
A consortium of international drug companies hopes to leverage their pooled schizophrenia data into a means of determining which patient subgroups are most likely to respond to treatment during clinical trials.
Nephrotoxicity Biomarker Prepares For Clinic After FDA Blesses Animal Test
The firms that obtained FDA/EMEA qualification of seven nephrotoxicity biomarkers for preclinical drug testing are midway through development of a protocol to test their efficacy in a clinical trial